Platelet-derived CXC chemokines: old players in new games

被引:136
|
作者
Brandt, E [1 ]
Ludwig, A [1 ]
Petersen, F [1 ]
Flad, HD [1 ]
机构
[1] Res Ctr Borstel, Dept Immunol & Cell Biol, D-23845 Borstel, Germany
关键词
D O I
10.1034/j.1600-065X.2000.17705.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although platelet factor 4 (PF-4) and the beta -thromboglobulin (beta -TG) proteins represent the first chemokines to be discovered, their functional roles in host defense became clear only recently. Residing in platelets as storage proteins and becoming released into the blood at very high concentrations, these mediators appear to fulfill different and complementary tasks as first-line mediators in the recruitment and activation of leukocytes, as well in the regulation of tissue repair. Whereas both proteins are structurally closely related members of the CXC chemokine subfamily, they are subject to quite dissimilar regulatory mechanisms controlling their generation and their spectrum of biological activities. Thus, proteolytic processing of inactive precursors plays a decisive role in whether the beta -TG proteins will act as stimulatory or inhibitory agents in neutrophil activation via the G protein-coupled receptors CXCR-1 and 2. PF-4, existing as a single molecular form, is largely resistant to proteolytic modification, but its interaction with an unusual recepror(s) on leukocytes (a proteoglycan) appears to depend on its oligomeric stare. There is growing evidence that both chemokines may interfere with each other at various regulatory levels to promote coordinated cell activation. Moreover, recent findings suggest novel and unexpected activities for these chemokines, which may extend our view on early host defense.
引用
收藏
页码:204 / 216
页数:13
相关论文
共 50 条
  • [21] PLATELET-DERIVED MICROVESICLES IN THROMBOCYTOPENIAS
    GALLI, M
    GRASSI, A
    BARBUI, T
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 999 - 999
  • [22] PLATELET-DERIVED COLLAGENASE INHIBITOR
    COOPER, TW
    STRICKLIN, GP
    EISEN, AZ
    WELGUS, HG
    CLINICAL RESEARCH, 1984, 32 (02): : A306 - A306
  • [23] Platelet-Derived Exosomes in Atherosclerosis
    Gardin, Chiara
    Ferroni, Letizia
    Leo, Sara
    Tremoli, Elena
    Zavan, Barbara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [24] Platelet-Derived Exosomes and Atherothrombosis
    Wei, Kangkang
    Huang, Hongbo
    Liu, Min
    Shi, Dazhuo
    Ma, Xiaojuan
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [25] Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions
    Baltus, T
    von Hundelshausen, P
    Mause, SF
    Buhre, W
    Rossaint, R
    Weber, C
    JOURNAL OF LEUKOCYTE BIOLOGY, 2005, 78 (02) : 435 - 441
  • [26] Platelet-Derived CCL5 Regulates CXC Chemokine Formation and Neutrophil Recruitment in Acute Experimental Colitis
    Yu, Changhui
    Zhang, Songen
    Wang, Yongzhi
    Zhang, Su
    Luo, Lingtao
    Thorlacius, Henrik
    JOURNAL OF CELLULAR PHYSIOLOGY, 2016, 231 (02) : 370 - 376
  • [27] PLATELET-DERIVED VASCULAR MEDIATORS
    SMITH, JB
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 320 - 320
  • [28] A new look at platelet-derived growth factor in renal disease
    Floege, Juergen
    Eitner, Frank
    Alpers, Charles E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (01): : 12 - 23
  • [29] Platelet-derived exosomes: a new vascular redox signaling pathway
    AO Carmo
    MA Pedro
    E Silva
    E Knobel
    FRM Laurindo
    M Janiszewski
    Critical Care, 7 (Suppl 3):
  • [30] New members of the platelet-derived growth factor family of mitogens
    Heldin, CH
    Eriksson, U
    Östman, A
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2002, 398 (02) : 284 - 290